We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Teva Pharmaceuticals and Par Pharmaceutical are facing a lawsuit in which the plaintiff alleges the companies’ generic versions of pergolide, a treatment for Parkinson’s disease and restless leg syndrome (RLS), caused her valvular heart disease.